Mannkind (MNKD) Total Current Liabilities (2010 - 2026)
Mannkind (MNKD) reported Total Current Liabilities of $134.6 million for Q1 2026, up 16.06% year-over-year from $115.9 million in Q1 2025, and down 21.32% quarter-over-quarter from $171.0 million in Q4 2025.
Mannkind (MNKD) Total Current Liabilities (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Total Current Liabilities data on file, last reported at $134.6 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $134.6 million, up 16.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $134.6 million (up 16.06% YoY), and the FY2025 annual result was $171.0 million, up 108.99% from the prior year.
- Total Current Liabilities slipped to $134.6 million in Q1 2026 per MNKD's latest filing, from $171.0 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $171.0 million in Q4 2025 and troughed at $53.5 million in Q1 2022.
- A 5-year average of $93.9 million and a median of $96.4 million in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities dropped 26.84% in 2022, then jumped 108.99% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $67.3 million in 2022, then surged by 54.73% to $104.1 million in 2023, then decreased by 21.41% to $81.8 million in 2024, then soared by 108.99% to $171.0 million in 2025, then slipped by 21.32% to $134.6 million in 2026.
- Business Quant data shows MNKD's Total Current Liabilities at $134.6 million in Q1 2026, $171.0 million in Q4 2025, and $109.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | 134.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134.56 Mn |
| Dec 31, 2025 | 171.03 Mn |
| Sep 30, 2025 | 109.13 Mn |
| Jun 30, 2025 | 111.83 Mn |
| Mar 31, 2025 | 115.94 Mn |
| Dec 31, 2024 | 81.84 Mn |
| Sep 30, 2024 | 72.10 Mn |
| Jun 30, 2024 | 80.01 Mn |
| Mar 31, 2024 | 99.90 Mn |
| Dec 31, 2023 | 104.13 Mn |
| Sep 30, 2023 | 96.37 Mn |
| Jun 30, 2023 | 96.97 Mn |
| Mar 31, 2023 | 81.85 Mn |
| Dec 31, 2022 | 67.30 Mn |
| Sep 30, 2022 | 59.60 Mn |
| Jun 30, 2022 | 59.56 Mn |
| Mar 31, 2022 | 53.49 Mn |
| Dec 31, 2021 | 48.35 Mn |
| Sep 30, 2021 | 50.03 Mn |
| Jun 30, 2021 | 60.43 Mn |